196 results
8-K
EX-99.1
ANIX
Anixa Biosciences, Inc.
8 May 24
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
8:35am
: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act
S-8
ANIX
Anixa Biosciences, Inc.
16 Jan 24
Registration of securities for employees
4:43pm
, including revenue from the settlement of litigation (during the year ended October 31, 2023, we derived approximately $210,000 of revenue from … our ability to develop and commercialize products and technology covered by these license agreements and we may be subjected to future litigation
8-K
EX-99.1
bgxo5 280y17gd5d7
7 Dec 23
Regulation FD Disclosure
6:01am
8-K
fggyr aev
7 Dec 23
Regulation FD Disclosure
6:01am
8-K
zr1bcmj ue3hwivfc08
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
8-K
EX-99.1
fuo8iur ii
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
8-K
zrl silvgwknl
8 Dec 22
Regulation FD Disclosure
8:40am
8-K
oh5dnsj il14d57xh7w
29 Sep 22
Regulation FD Disclosure
8:30am